[1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024; 74, 229−63.
[2] Jiang YF, Li ZY, Ji XW, et al. Global pattern and trend of liver cancer survival: a systematic review of population-based studies. Hepatoma Res, 2020; 6, 52.
[3] Chakraborty A, Pant MD. Machine learning models for pancreatic cancer survival prediction: a multi-model analysis across stages and treatments using the surveillance, epidemiology, and end results (seer) database. J Clin Med, 2025; 14, 4686. doi:  10.3390/jcm14134686
[4] Rich NE, Murphy CC, Yopp AC, et al. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment Pharmacol Ther, 2020; 52, 701−09. doi:  10.1111/apt.15917
[5] Kim SY, Song HK, Lee SK, et al. Sex-biased molecular signature for overall survival of liver cancer patients. Biomol Ther (Seoul), 2020; 28, 491−502. doi:  10.4062/biomolther.2020.157
[6] Iheanacho F, Tramontano A, Manz C. Racial disparities in hepatocellular carcinoma (HCC) treatment and survival: a SEER-medicare analysis. JCO Oncol Pract, 2024; 20, 144. doi:  10.1200/OP.2024.20.10_suppl.144
[7] Rich NE, Jones PD, Zhu H, et al. Impact of racial, ethnic, and socioeconomic disparities on presentation and survival of HCC: a multicenter study. Hepatol Commun, 2024; 8, e0477.
[8] Penzkofer L, Gröger LK, Hoppe-Lotichius M, et al. Mixed hepatocellular cholangiocarcinoma: a comparison of survival between mixed tumors, intrahepatic cholangiocarcinoma and hepatocellular carcinoma from a single center. Cancers (Basel), 2023; 15, 639. doi:  10.3390/cancers15030639
[9] Wei TT, Huang HB, Zhang AJ, et al. Impact of the diagnosis-to-treatment interval on the survival of patients with papillary thyroid cancer. J Invest Surg, 2025; 38, 2456463. doi:  10.1080/08941939.2025.2456463
[10] Gao Y, Liu J, Zhao DX, et al. A novel prognostic model for identifying the risk of hepatocellular carcinoma based on angiogenesis factors. Front Genet, 2022; 13, 857215. doi:  10.3389/fgene.2022.857215